J-Pharma Co (TSE:520A) Short-Term Debt: 円0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円284.00
View Full Analysis

What is J-Pharma Co Short-Term Debt?

J-Pharma Co TSE:520A +3.65% 9 Short-Term Debt is 円0.00 Mil as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

J-Pharma Co's Short-Term Debt for the quarter that ended in Dec. 2025 was 円0.00 Mil.

J-Pharma Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

J-Pharma Co Short-Term Debt Related Terms

J-Pharma Co Short-Term Debt Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Short-Term Debt Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Short-Term Debt
0.00 0.00

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Short-Term Debt 0.00 0.00 0.00
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of 円0.00 Mil mean?
J-Pharma Co (TSE:520A) has a Short-Term Debt of 円0.00 Mil as of Dec. 2025.
Is J-Pharma Co's Short-Term Debt too high?
J-Pharma Co's current Short-Term Debt is 円0.00 Mil. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Short-Term Debt compare to VRTX and REGN?
J-Pharma Co's Short-Term Debt of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Biotechnology company?
A good Short-Term Debt depends on the Biotechnology industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. J-Pharma Co's current Short-Term Debt is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Short-Term Debt of 円0.00 Mil. The current Short-Term Debt is 円0.00 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Short-Term Debt is 円0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円284.00
Price